The "Godfather of ecstasy" had held out hope that clinical trials would reveal medicinal benefits of new psychedelic drugs.
Researchers used an emerging technique to correct the gene behind a fatal immune system disorder in an infant.
An electromechanical limb developed by Segway maker DEKA now needs a manufacturer to mass-produce it.
Electronics companies think the Affordable Care Act will push us to embrace technology to track our health and lifestyles.
Chinese biomedical engineers have used liquid metal to transmit electrical signals across the gap in severed sciatic nerves. The work raises the prospect of a new treatment for nerve injuries, they say.
By defocusing a microscope, biologists have developed a simple technique that produces three-dimensional images of red blood cells.
Research suggests that electronic health information is particularly vulnerable to software bugs.
The Harvard-MIT genomic science institute stays mute on how it will assert control over the tools expected to speed cures and change gene therapy.
The most extensive collaboration between the patient social network and a drug company to-date is likely to be just the first of its kind.
Many are eager to trot out GMOs as the answer to our food problems. But lower-tech alternatives work better.